LKFT
Galapagos N.V. Sponsored ADR
NASDAQ · Healthcare · Biotechnology · US
$28.49
−1.83%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 46.66x
Trailing multiples
Trailing twelve months
- P/E TTM
- 2.71x
- PEG TTM
- —
- Price / book
- 0.49x
- Price / sales
- 1.62x
- Price / cash flow
- -8.32x
Enterprise value
- Enterprise value
- -$729.3M
- EV / sales
- -0.63x
- EV / EBITDA
- -1.16x
- EV / EBIT
- -1.03x
- Market cap
- $1.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026